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SUMMARY. Hyoscyamine, 6β-hydroxyhyoscyamine and scopolamine are anticholinergic agents that be-
long to the tropane alkaloids, a pharmacological important group of secondary metabolites. Hyoscyamine
and scopolamine were historically used in medicine. Additionally, potential medical applications for 6β-
hydroxyhyoscyamine were described in the last years. Previous works carried out in our lab allowed us
the construction of a Saccharomyces cerevisiae strain harboring the Hyoscyamine-6β-hydroxylase (H6H)
enzyme which is responsible of the conversion of hyoscyamine into 6β-hydroxyhyoscyamine and scopo-
lamine. Several factors influenced and complicated the optimization of the hyoscyamine bioconversion
process. The aim of this work was to evaluate the analytical factors that critically affect the performance
of the alkaloid extraction and the detection and quantification method of the alkaloids implied in the bio-
catalytical process. The mechanical breakdown of yeast cells by continuous agitation at 4 °C in 2 mL tubes
was the method of choice for an efficient recovery of the functional H6H enzyme. In addition, the different
pH assayed for the alkaloid extraction caused significant variations in the recovery of the alkaloids, specif-
ically impacting on scopolamine recovery which decreased a 35 % after the increase of the pH of the ex-
traction. The development of robust and sensitive analytical methods was requisite for the correct moni-
toring and quantification of the alkaloids produced in order to evaluate the technological and economic
feasibility of this process.
INTRODUCTION
Hyoscyamine-6β-hydroxylase (H6H, EC 1.14.
11.11) is the final enzyme of the tropane alkaloid
biosynthetic pathway and catalyzes the conver-
sion of hyoscyamine into 6β -hydroxy-
hyoscyamine (also called anisodamine) and
scopolamine by two sequential reactions (Fig. 1). 
Hyoscyamine and scopolamine are anti-
cholinergic agents that have been extensively
used as pharmaceuticals 1,2. In addition to the
anticholinergic action, further therapeutic prop-
erties were described for 6β-hydoxyhyoscymine
that includes the treatment of microvascular dis-
eases, glomerulonephritis, rheumatoid arthritis,
gastrointestinal colic, hemorrhagic necrotic en-
teritis, eclampsia as well as the control of toxic
shock, septic shock, and organophosphorus
poisoning 3. Additionally, this alkaloid is not as
toxic as atropine (dl-hyoscyamine) having lesser
negative effects on the Central Nervous System
than scopolamine 3. 
Nowadays these alkaloids are extracted from
producer plants belonging to the Solanaceae
family. Also, they can be synthesized chemically
4, however, the chemical synthesis is complicat-
ed and time consuming. The biotransformation
Figure 1. Hyoscyamine (1), 6β-hydoxyhyoscyamine
(2) and scopolamine (3) chemical structures.
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of hyoscyamine is an attractive strategy for 6β-
hydroxyhyoscyamine and scopolamine produc-
tion 5 due to the reason mentioned above, the
fact that scopolamine has a 10-times higher
commercial demand than that of hyoscyamine 6
and the increased interest in 6β -hydroxy-
hyoscyamine for medical applications. 
However, the success in the conversion of
alkaloids was influenced by various factors. For
an accurate evaluation of the transformation
products, the development of efficient and pre-
cise analytical methods was necessary in order
to ensure a complete isolation, detection and
quantification of the alkaloids.
The aim of this work was to evaluate the an-
alytical factors that critically impact on the moni-
toring of the conversion, including the influence
of the alkaloid extraction and the detection and
quantification method of the alkaloids involved
in the biotransformation process, among others.
MATERIALS AND METHODS
Strains and genetic constructions for H6H
production
The recombinant yeast strain used in this
work was previously described 5. Briefly, the
wild type strain S. cerevisiae CEN PK2 (Acc. No.
30000D, Eurofan) (Mata/Matα ura3-Δ2/ura3-Δ2
trp1-289/trp1-289 leu2-3, 112/leu2-3, 112
his3Δ1/his3Δ1 mal2-8 C/mal2-8 C suc2/suc2)
was kindly supplied by Dr. Susana Silverstein,
IFYBINE-FCEN UBA. S. cerevisiae wild type
strain was grown in YPD medium (10 g yeast
extract/l, 20 g peptone/l, 20 g glucose/l) at 30
°C. The h6hcDNA 5,7 was inserted into the
pYES2.1 vector from Invitrogen in order to pro-
duce the H6H enzyme in yeast. The recombi-
nant yeast strain was maintained in the selection
medium YNBD-U (yeast nitrogen base without
uracil).
Yeast cell lysis
Different methodologies were assayed in or-
der to obtain enough quantities of the recombi-
nant H6H enzyme: mechanical breakdown, son-
ication, and liquid nitrogen freezing and grind-
ing with mortar and pestle.
Mechanical breakdown 
The yeast cell pellet corresponding to an op-
tical density (OD) of 60 was washed twice with
phosphate buffer 50 mM, pH 7.8 and resus-
pended in Breaking Buffer (Phosphate buffer 50
mM, pH 7.8, glycerol 8 % and protease inhibitor
cocktail from Roche). The cell suspension was
mixed with an equal volume of glass beads (0.4
– 0.6 mm).
Classical method. Yeast cells were lysed in
1.5 mL tubes by vortexing at maximum speed
for 30 s followed by 30 s chilling on ice. This
procedure was repeated 4 times. The lysate ob-
tained was transferred to a fresh tube.
Scale up. The operating conditions applied
in this case were the same that those described
above. Particularly in this case, the 1.5 mL tubes
were replaced by 15 mL conical tubes scaling
the volume of the cell pellet lysed. The lysate
obtained was transferred to a fresh tube.
Continuous agitation. The cell lysis was per-
formed by vortexing continuously at maximum
speed for 20 min at 4 °C. Additionally, the 1.5
mL tubes were replaced by 2 mL tubes. The
lysate obtained was transferred to a fresh tube.
The total protein content was measured by the
Bradford method 8.
Sonication
Yeast cells were washed and resuspended in
breaking buffer as it was previously described.
The yeast cell suspensions were sonicated using
a Sonics & Materials inc. Sonicator (Danbury,
Connecticut, USA). Different power (50W, 80W
and 100W) and time (30 s, 1, 2, 5, and 10 min)
combinations were applied followed by short
cooling periods.  After the treatments the sam-
ples were centrifuged al 10000 rpm for 10 min
and the supernatant assayed for total proteins
by the Bradford method 8.
Liquid nitrogen freezing and grinding with mor-
tar and pestle
Yeast cells were placed in mortar and
ground with liquid nitrogen. After this treatment
the sample was resuspended in breaking buffer
and centrifuged as it was described above. The
supernatant assayed for total proteins by the
Bradford method 8.
Biotransformation assay
The transformation of hyoscyamine by crude
preparations of the recombinant H6H was as-
sayed by measuring its conversion into 6β-hy-
droxyhyoscyamine and scopolamine 5. The reac-
tion mixture includes 50 mM Tris-HCl buffer
(pH 7.8 at 30 °C), 4 mM sodium ascorbate, 0.4
mM FeSO4, 1 mM 2-oxoglutarate, 0.2 mM l-
hyoscyamine hydrobromide, 500 µl catalase 9,10.
The reaction was started by the addition of the
crude extract containing the H6H enzyme and
stopped by the alkalinization of the reaction
mixture with carbonate buffer pH 10. 
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Alkaloid extraction
The alkaloid extraction was performed at pH
9 and 12 with 5 mL chloroform (ratio 1:1 v/v)
by continuous vortexing for 2 min 11,12. Samples
were extracted three times and the organic
phases obtained were pooled and evaporated
under gaseous N2 at room temperature. The
residue was dissolved in methanol-water (50:50
v/v) and filtered through a 0.45 µm pore nylon
membrane.
Analytical Methods
HPLC analysis of the alkaloids was per-
formed on a Shimadzu LC-20AT system with a
LiChro CART column 125–4 Lichrospher 60 RP-
select B (5 µm), Merck. The elution was per-
formed at 40 °C, isocratically with Octanesulfon-
ic acid 0.01 M pH3/Metanol (65:35 v/v) at a 1
mL/min flow rate. The detection was performed
at 220 nm. 
Statistical analysis
Results are means of three independent ex-
periments. Sample variability was given as the
standard deviation of the mean. The statistical
significance was evaluated by performing a T
test. Differences between means were consid-
ered significant when p < 0.05. Statistical analy-
ses were performed by the InfoStat software.
RESULTS AND DISCUSSION 
Since the recombinant S. cerevisiae strain
used in this work produces the H6H enzyme in-
tracellularly 5 it was necessary performing the
yeast cell lysis in order to obtain the enzyme. It
is well known that the efficient yeast cell lysis is
one of the main issues associated with the uti-
lization of yeast for biotechnological purposes.
S. cerevisiae is considered one of the most diffi-
cult microorganisms to disrupt 13. Frequently,
the cell wall characteristics complicate the
downstream processing leading to protein isola-
tion and purification 14. For this reason, different
methodologies were assayed in order to obtain
enough quantities of the recombinant H6H en-
zyme. 
Firstly, the mechanical lysis using glass beads
was assayed as it is described in Material and
Methods section. Under these working condi-
tions (classical method) the total protein content
obtained was 81.15 ± 0.81 µg/mL (Fig. 2). Addi-
tionally, the scale up of the method (scale up)
was assayed using 15 mL conical tubes. The
protein content obtained in this case was 118.31
± 6.07 µg/mL (Fig. 2). These findings show that
Figure 2. Total proteins measured after the applica-
tion of the different variants to the mechanical lysis
method. 
the modifications included allowed us the pro-
cessing of higher volumes of yeast culture main-
taining protein yields. Further modifications of
the classical method such us the employment of
2 mL tubes and the continuous agitation at 4 °C
(Continuous agitation) increased protein yield
up to 5.93 ± 0.067 mg/mL (Fig. 2).
Secondly, the disruption of yeast cells was
assayed by sonication. Different treatments were
applied varying the potencies and time of expo-
sure as it is described previously. However, the
protein yields obtained under these conditions
were slightly higher than those obtained for the
mechanical lysis using the 15 mL conical tubes
(data not shown). Nevertheless, the protein
yield was significantly higher when the mechan-
ical method modified by continuous agitation at
4 °C was applied compared to the sonication of
samples.
Thirdly, the manual grinding in a mortar us-
ing liquid nitrogen was analyzed for the yeast
cells lysis. The application of this method was
complicated and protein yield was low or not
detectable.
The enzymatic lysis of the cell wall is another
possibility to obtain large amounts of proteins
from yeast. However, enzymatic digestion can
be expensive when working with large quanti-
ties of samples 14. Also, an additional step is
commonly required to lyse the spheroplasts gen-
erated by the lytic enzymes (e.g. lyticase, zymo-
lase) increasing the cost of protein isolation 15.
For the reasons mentioned above, the me-
chanical breakdown of yeast cells including
modifications such as the continuous agitation
at 4 °C and the application of 2 mL tubes was
the method of choice to obtain enough quanti-
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ties of the H6H enzyme maintaining its function-
ality.
For evaluation of the hyoscyamine biotrans-
formation using the recombinant H6H enzyme
produced in S. cerevisiae it was necessary to op-
timize various factors that were critical in the al-
kaloid extraction from the samples and the mea-
surement of them.
Regarding to alkaloid extraction, the factors
considered were the pH for the organic extrac-
tion, the agitation conditions to allow the trans-
fer of the alkaloid molecules to the organic
phase and the evaporation conditions of the or-
ganic extract among others.
Previous works carried out with tropane al-
kaloids have reported different working condi-
tions in relation to the pH of the extraction.
These values varied between 8 to 12 16,17.
Figure 3 shows the recovery of hyoscyamine
and scopolamine after their isolation at pH 9
and 12. Although hyoscyamine recovery falls
from 92.33 ± 18.01 % at pH 9 to 77.56 ± 0.83 %
at pH 12, this difference was not statistically sig-
nificant. However, scopolamine recovery de-
creased a 35 % after the increase of the pH of
the extraction. This difference was statistically
significant (p = 0.001). 
The assays performed have shown the re-
quirement to optimize the methodological con-
ditions in the extraction of alkaloids since differ-
ent pH assayed caused variations in the recov-
ery of them. This fact is probably related to the
hydrolysis of the molecule exposed at alkaline
pH values. Specifically considering
hyoscyamine, although the decrease in the re-
covery was not statistically significant it should
be careful choosing the working conditions to
ensure the correct monitoring of the variations
in its content. 
The agitation cycles to promote the transfer
of the alkaloids to the organic phase had a
slightly influence in the recovery of tropane al-
Figure 3. Recovery of hyoscyamine (A) and scopo-
lamine (B) after the chloroform extraction performed
at pH 9 and 12.
Figure 4. Influence of different factors on the recov-
ery of hyoscyamine (A) and scopolamine (B). H and
S: control condition; H 30 °C and S 30 °C: samples in-
cubated at 30 °C previously to the extraction; H 50:50
and S 50:50: isolation form mixtures; H 50 °C and S
50 °C: samples evaporated at 50 °C. 
kaloids. Continuous agitation for 2 min was
more effective than the sum of 30 s cycles (data
not shown). 
Also, other factors that might affect the re-
covery of tropane alkaloids were analyzed (Fig.
4a and b). Among them, the influence of the in-
cubation of the alkaloids at 30 °C for 2 h as they
are exposed during the enzyme activity assays
was considered. This condition was analyzed in
order to evaluate whether degradation of
tropane alkaloids exist during the biotransforma-
tion process. Another factor analyzed was the
effect of evaporating the organic extracts at 50
°C on the recovery percentage of the alkaloids.
Additionally, the recovery of each alkaloid was
evaluated when they are isolated from mixtures.
The conditions assayed did not significantly af-
fect the recovery of hyoscyamine and scopo-
lamine (Fig. 4). 
Regarding to the optimization of the alkaloid
detection and quantification method, it was cru-
cial the development of an analytical method
that allowed us the detection of small quantities
of tropane alkaloids in order to follow the bio-
transformation processes.  
For the detection of the alkaloids present in
plants, the method applied previously in our lab
17,18 had enough sensitivity. This method was
carried out using a LiChro CART column 250-4
RP-18 (5 µm), Merck. The elution was per-
formed at 40 °C, isocratically with 1 % trietil-
amine-formic acid/ethanol (9:1 v/v) at a 1
mL/min flow rate. However, for monitoring the
conversion of hyoscyamine into its products by
the recombinant enzyme it was necessary to op-
timize an HPLC method in order to achieve re-
producibility, sensitivity, and an optimum reso-
lution of the alkaloid peaks. In this way, differ-
ent modifications were introduced to methods
described in bibliography 19. 
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In order to avoid the tailing effects on the al-
kaloid peaks we changed the stationary phase
of the HPLC column. A LiChro CART column
125–4 Lichrospher 60 RP-select B (5 µm) was
successfully employed for the analysis of
tropane alkaloids. 
Several works, reviewed by Dräger 20,
demonstrated that it is possible to separate and
quantify tropane alkaloids by HPLC using differ-
ent solvent systems. Among them we can men-
tion the potassium phosphate buffer (pH 2.7)
with 17 % acetonitrile, methanol-water (40:60,
pH 7.25, triethyl ammonium phosphate 0.2 %),
tetrahydrofuran containing 1 % ammonia, tri-
ethylamine and formic acid pH 3.5, acetonitrile-
Figure 5. (A) HPLC chromatogram obtained by the method described by Mano et al. 17 after the injection of a
1000 ppm mixture of hyoscyamine and scopolamine. (B) HPLC chromatogram obtained by the optimized
method after the injection of 10 ppm mixture of hyoscyamine, 6β-hydoxyhyoscyamine and scopolamine.
6β-hydroxyhyoscyamine (%) Scopolamine (%)
Time (h) 2 15 2 15
H6H 53.7 83.3 - 7.6
Negative control - - - -
Table 1. Biotransformation products obtained from hyoscyamine by H6H catalytic activity 5. The percentage val-
ues of 6β-hydroxyhyoscyamine and scopolamine are the means of three independent determinations which dif-
fers in no more than 10 %.
water-acetic acid-tetrahydrofuran (50:50:5:2) and
a buffered triethylamine-phosphoric acid 30
mM, pH 2.2 aqueous acetonitrile mixture (12.5
% acetonitrile). In order to separate, analyze and
quantify tropane alkaloids we successfully em-
ployed a solvent system conformed by different
proportions of octanesulfonic acid 0.01M (pH 3)
and methanol 21. The working conditions select-
ed which permitted the separation of the three
alkaloids under analysis are detailed in the Ma-
terial and Methods section 5,11.
Even though it was possible to separate the
alkaloids at room temperature (data not shown),
we decided to work under temperature con-
trolled conditions. The analysis was carried out
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at 40 °C in order to accelerate the alkaloid elu-
tion, reduce the chromatographic times and to
obtain reproducible chromatograms.
Under these experimental conditions it was
possible to reach a good resolution between
picks maintaining an acceptable running time.
The detection limit was 2 ppm of each alkaloid
with a resolution factor of 2.6. 
Figure 5 shows the typical chromatograms
obtained by both HPLC methods. The first
method was not sensitive enough for the alka-
loid analysis during the biocatalytic processes.
The concentrations injected in the present assay
were highly superior to those present in the bio-
conversion assays. 
The optimization of all the factors mentioned
above allowed us to perform and to study tight-
ly the biotransformation of hyoscyamine by the
H6H enzyme 5.
Table 1 shows the percentages of the alka-
loids produced in the biotransformation assays.
The H6H enzyme was able to transform
hyoscyamine into more valuable alkaloids,
scopolamine and 6β-hydroxyhyoscyamine. 
The results obtained in this work indicated
that it is necessary to analyze in depth the dif-
ferent methods for yeast cell lysis for an efficient
recovery of the functional H6H enzyme. In this
case, the mechanical breakdown of yeast cells
including modifications such as the continuous
agitation at 4 °C and the application of 2 mL
tubes was the method of choice. Also, the anal-
ysis of experimental variables that affects the
isolation and quantification of hyoscyamine, 6β-
hydroxyhyoscyamine and scopolamine was es-
sential in order to follow the hyoscyamine bio-
transformation by the H6H enzyme.  Our stud-
ies also highlight the importance of having a re-
liable method for the alkaloid extraction that did
not affect significantly the recovery of them after
the isolation from the samples. This was essen-
tial to ensure the detection of small amounts of
the alkaloids transformed by the enzyme. 
The correct monitoring of the quantities pro-
duced of each alkaloid during hyoscyamine bio-
transformation process is essential in order to
evaluate the technological and economic feasi-
bility of this process of interest for the pharma-
ceutical industry. For this reason, the develop-
ment of a robust and sensitive analytical method
was requisite for the detection and quantifica-
tion of hyoscyamine, 6β-hydoxyhyoscyamine
and scopolamine.  
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